Adlai Nortye ANL
NASDAQ ANL
$15.96 +0.31 (+1.98%)
As of: Sep 30, 2026 · 3:58 PM EDT

Adlai Nortye (ANL) Total Non-Current Liabilities (2022 - 2026)

Updated

Adlai Nortye (ANL) reported Total Non-Current Liabilities of $8.31 million for Q2 2026, compared with $257,000 a year earlier.

Analysis

Adlai Nortye (ANL) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye posted Total Non-Current Liabilities of $1.13 million, up 165.2% from FY2024.

  • Total Non-Current Liabilities has a three-year compound annual growth rate of -3.0% (FY2022 to FY2025).
  • By year, Total Non-Current Liabilities came in at $425,000 in FY2024 (-92.2%), $5.47 million in FY2023 (+342.5%) and $1.24 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Adlai Nortye 537.37 Mn 438.08 Mn - 8.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.31 Mn
Dec 31, 2025 1.13 Mn
Jun 30, 2025 257,000.00
Dec 31, 2024 425,000.00
Dec 31, 2023 5.47 Mn
Dec 31, 2022 1.24 Mn
API Access

Adlai Nortye Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANL&period=max&api_key=YOUR_API_KEY